Icon Cancer Centre

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Ovarian cancer2 trials
• Bladder cancer1 trial
• Colorectal cancer1 trial
• Glioblastoma1 trial
• Lung cancer1 trial
• Pancreatic cancer1 trial

Phase

• Phase 24 trials
• Phase 32 trials
• Phase 11 trial
• Phase 1/21 trial

Status

• Recruiting4 trials
• Active, not recruiting3 trials
• Completed1 trial

Lead sponsor

• Akeso1 trial
• BicycleTx Limited1 trial
• Corvus Pharmaceuticals, Inc.1 trial
• Genmab1 trial
• Kahr Bio Australia Pty Ltd1 trial
• and 3 more

Running trials

• Recruiting

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  NCT07644559· Phase 2· Verastem, Inc.· Source

  Contact: Apryl Chelin

• Recruiting

  A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

  NCT07235293· Phase 2· Kahr Bio Australia Pty Ltd· Source

  Contact: Jermaine lan George Coward, A/Prof (principal investigator)

• Recruiting

  A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

  NCT07226427· Phase 1· Stemline Therapeutics, Inc.· Source

  Contact: Stemline Trials

• Active, not recruiting

  Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer

  NCT06619236· Phase 3· Genmab· Source

• Recruiting

  Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

  NCT06561048· Phase 3· Corvus Pharmaceuticals, Inc.· Source

  Contact: Study Director

• Active, not recruiting

  Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

  NCT06225596· Phase 2· BicycleTx Limited· Source

• Active, not recruiting

  Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM

  NCT04195139· Phase 2· University of Sydney· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting

Closed trials

• Completed

  A Study of AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer

  NCT05505825· Phase 1/2· Akeso· Source